Back to search

Finland· FI-REL-REL62803

Rotigotine Medical Valley

A rotigotine product containing rotigotine, registered in Finland by Medical Valley Invest AB. The same ATC class is registered in 18 of our 19 countries.

ATC N04BC09

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedRotigotine Medical ValleyATCN04BC09REGISTER NO.FI-REL-REL62803PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Rotigotine is registered in 18 of 19 countries.

Countries holding a registration under ATC N04BC09 (rotigotine), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 10 of them publish a price we can compare per daily dose

Rotigotine · ATC N04BC09

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of rotigotine costs, country by country.

Normalised to the WHO defined daily dose (6 mg), the median price runs from $0.77 in Czechia to $4.34 in Switzerland — a ×5.6 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Rotigotine · price per daily dose (6 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$4.34
  • CZ Czechia$0.77
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Fimea (Finland)
Active substance
Rotigotine
Manufacturer
Medical Valley Invest AB
Country
Finland (FI)
ATC code
N04BC09
ATC class
Rotigotine
Defined daily dose
6 mg, TD
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 1

1 priced
  • fi_myyntilupa
    390653
    28
    EUR 37.41

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

58 interactions on record for rotigotine.

Graded by severity as the source publishes them — 58 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Rotigotine · interactions on record

58 records

  • 58 moderate

Most severe, free to view

  • MetoclopramideA03FA01moderate
  • ThiethylperazinA04AB03moderate
  • DiphenhydraminA04AB05moderate
  • DronabinolA04AD10moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Rotigotine in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rotigotine products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Austria · Kinparlev, Rotigotin Gebro
  • Germany · Rotigotin Luye, Rotigotin Neuraxpharm
  • Denmark · Kinparlev, Rotigotine Medical Valley
  • Spain · Dariante
  • France · Rotigotine Arrow
  • Greece · Kinparlev
  • Iceland · Neupro, Rotigotine Medical Valley
  • Italy · Rotigotina Doc
  • Liechtenstein · Neupro
  • Luxembourg · Rotigotin Luye
  • Netherlands · Rotigotine Medical Valley, Rotigotine Xiromed
  • Norway · Kinparlev, Neupro
  • Portugal · Kinparlev, Rotigotina Generis
  • Romania · Kinparlev
  • Sweden · Kinparlev, Rotigotine Medical Valley

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c42c88ed-816b-4cfa-894c-6ac4e3221c2f
GET /v1/drugs/c42c88ed-816b-4cfa-894c-6ac4e3221c2f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "6",
  "form": "depotlaastari",
  "route": "Ihon läpi",
  "ddd_unit": "mg",
  "strength": "2 mg / 24 tuntia",
  "atc_label": "rotigotiini",
  "ma_number": "43742",
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": null,
  "fimea_rel_id": "REL62803",
  "authorised_at": "2024-10-25"
}

See everything about rotigotine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.